247 related articles for article (PubMed ID: 15790640)
1. Changes to India's patent law may deny cheap drugs to millions.
Mudur G
BMJ; 2005 Mar; 330(7493):692. PubMed ID: 15790640
[No Abstract] [Full Text] [Related]
2. Legal challenge to India's patent laws threatens access to generic drugs, says charity.
Moszynski P
BMJ; 2011 Sep; 343():d5753. PubMed ID: 21908529
[No Abstract] [Full Text] [Related]
3. India's new patent laws may still hurt generic drug supplies.
Chatterjee P
Lancet; 2005 Apr 16-22; 365(9468):1378. PubMed ID: 15841559
[No Abstract] [Full Text] [Related]
4. Intellectual property. Challenges to India's pharmaceutical patent laws.
Sampat BN; Shadlen KC; Amin TM
Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
[No Abstract] [Full Text] [Related]
5. India's rejection of Novartis's patent is but a small step in the right direction.
Bhaumik S
BMJ; 2013 Apr; 346():f2412. PubMed ID: 23596223
[No Abstract] [Full Text] [Related]
6. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
7. The production of generic drugs in India.
Love J
BMJ; 2011 Mar; 342():d1694. PubMed ID: 21427048
[No Abstract] [Full Text] [Related]
8. India's patent laws under pressure.
Roderick P; Pollock AM
Lancet; 2012 Sep; 380(9846):e2-4. PubMed ID: 22988579
[No Abstract] [Full Text] [Related]
9. Indian generic drug production. Benefits of EU-India free trade agreement.
Ager B
BMJ; 2011 Apr; 342():d2439. PubMed ID: 21502277
[No Abstract] [Full Text] [Related]
10. Impact of India's new patents law 2005: a physician's perspective.
Lele RD
J Assoc Physicians India; 2005 Aug; 53():671-5. PubMed ID: 16398073
[No Abstract] [Full Text] [Related]
11. Novartis challenges India's drug patent laws in Supreme Court.
Billingsley M
BMJ; 2012 Feb; 344():e1279. PubMed ID: 22354594
[No Abstract] [Full Text] [Related]
12. Canada to change patent law to allow export of cheap drugs.
Kondro W
Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
[No Abstract] [Full Text] [Related]
13. Taking TRIPS to India--Novartis, patent law, and access to medicines.
Mueller JM
N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
[No Abstract] [Full Text] [Related]
14. Big Pharma vs India’s Patent Office.
Pharm Pat Anal; 2012 Nov; 1(5):529. PubMed ID: 24236921
[No Abstract] [Full Text] [Related]
15. India's patent case victory rattles Big Pharma.
Chatterjee P
Lancet; 2013 Apr; 381(9874):1263. PubMed ID: 23589911
[No Abstract] [Full Text] [Related]
16. Engineered in India--patent law 2.0.
Kapczynski A
N Engl J Med; 2013 Aug; 369(6):497-9. PubMed ID: 23862973
[No Abstract] [Full Text] [Related]
17. India's patent ecosystem - encouraging strong patents or discouraging innovation?
Harrison C
Nat Rev Drug Discov; 2013 Oct; 12(10):732-3. PubMed ID: 24080690
[No Abstract] [Full Text] [Related]
18. India's new patent bill threatens generic industry.
Ahmad K
Lancet Infect Dis; 2005 May; 5(5):265. PubMed ID: 15889471
[No Abstract] [Full Text] [Related]
19. Amendments to the Canadian Patent Act to address drug access: is help on the way?
Penner MD; Narayanan P
Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
[No Abstract] [Full Text] [Related]
20. TRIPS: generic irony.
Howarth GR
Br J Gen Pract; 2002 Jan; 52(474):57. PubMed ID: 11791819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
